Pfizer Warns of Bextra Risks

Safety of All COX-2 Inhibitors Questioned

October 16, 2004
Pfizer has issued a warning that its popular pain killer Bextra could increase the risk of heart attack or stroke in patients who have undergone heart bypass surgery.

Bextra • Consumer Complaints • FDA Blasts Ads For Celebrex, Bextra • FDA Strengthens Bextra Warnings • Bextra Doubles Risk of Heart Attack and Stroke, Study Finds • Pfizer Warns of Bextra Risks --- Other NSAIDs • Vioxx • Celebrex • Aleve Ingredient Seen as Health Risk

Bextra is a COX-2 inhibitor, as is Vioxx, withdrawn by Merck earlier this month after studies showed it increased the risk of heart attack or stroke in patients who took it longer than 18 months.

In its warning to doctors, Pfizer said a clinical study of 1,500 patients showed that those who had undergone coronary bypass surgery and taken Bextra intravenously and orally were at high risk for heart attacks. A similar study last year reached the same conclusion.

Vioxx, Bextra and other popular COX-2 inhibitors, including Pfizer's Celebrex, are widely prescribed for patients suffering from arthritis and other painful conditions. Celebrex is the best-selling COX-2 drug. Bextra is a newer, faster-acting version of Celebrex.

Pfizer said it is now conducting tests to determine whether Bextra increases heart attack risk in patients who take it for chronic pain.

The latest warnings contradict Pfizer's earlier assurances that its COX-2 drugs are safe. On October 7, the company said clinical trails had shown that Celebrex does not pose the same risks as Vioxx and said patients have no reason to be concerned.

In fact, the study that demonstrates the Bextra problem was conducted last spring.

Pfizer repeated its contention yesterday that Bextra and Celebrex are chemically different from Vioxx and do not carry the same risks.

The U. S. Food and Drug Administration (FDA) said it will convene a meeting of experts in January to consider safety concerns involving Bextra and Celebrex.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Follow us on Twitter.

Back to the top |

Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2010 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.